Cancer

Cellular and molecular interactions around tumors give insight into their structures and weaknesses, but measuring them has been expensive and slow. A Stanford Medicine AI platform flips the script.

Antibody therapies show limited success in solid tumors. A new Stanford Medicine imaging method, precise enough to locate antibodies at subcellular resolution, hints at why.

Modulating a molecular seesaw could reduce inflammation, aid wound healing, and curb skin cancer growth.

A new drug is doubling survival times for one of the deadliest cancers. Stanford Medicine’s Daniel Delitto breaks down how it works and what else is on the horizon.

A proposed cancer center in Redwood City would combine care and research to advance treatments for a growing patient population.

Stanford Medicine researchers found a way to enhance natural killer cells to better infiltrate and fight solid tumors in mice, with implications for more accessible cancer treatment.

Stanford Medicine’s new proton therapy facility is ready for patients. A child with a rare brain tumor became the first to receive treatment.

Research indicates that changes to Medicaid’s retroactive eligibility may leave newly diagnosed gastrointestinal cancer patients facing substantial, unanticipated medical expenses.

A new study shows how a noninvasive blood test can identify nine tumor neighborhoods, predicting microenvironments that affect patient responses to immunotherapy.

A $10 million commitment aims to help the American Cancer Society build a new Hope Lodge, providing temporary lodging for cancer patients traveling to the Bay Area for treatment.